1-3 of 3
María Díez-Campelo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pivotal Results of SELECT-MDS-1 Phase 3 Study of Tamibarotene with Azacitidine in Newly Diagnosed Higher-Risk MDS

Open Access
Clinical Trials & Observations
Amy E. DeZern, Sylvain Thepot, Stéphane De Botton, Andrea Patriarca, Dries Deeren, Jose Miguel Torregrose Diaz, Giovanni Marconi, Teresa Bernal del Castillo, Juan Miguel Bergua Burgues, Blanca Xicoy, Anna Jonasova, Amer M. Zeidan, Sophie Dimicoli-Salazar, Célestine Simand, David Valcárcel, María Díez-Campelo, Wanxing Chai-Ho, Lalit Saini, Alice Garnier, Klaus Geissler, Yishai Ofran, Zsolt Nagy, Pramila Krishnamurthy, Michael Lübbert, Grzegorz W. Basak, Hetty E Carraway, David A. Sallman, Uma Borate, Valeria Santini, Victoria Campbell, Pierre Fenaux, Thorsten Braun, Francesco Lanza, Jan Maciej Zaucha, David A Roth, Sofia Paul, Pourab Roy, Michael Kelly, Angela Volkert, Jaime Chisolm, Tanya Abdul Malak, Virginia Klimek, Thomas Cluzeau
Journal: Blood Advances
Blood Adv bloodadvances.2025016229.
https://doi.org/10.1182/bloodadvances.2025016229
Published: 2025
Includes: Supplemental data
Journal Articles

AML typical mutations ( CEBPA , FLT3 , NPM1 ) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular

Free
Clinical Trials & Observations
Sandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti, Xavier Calvo, Felicitas Isabel Schulz, Alejandro Avendaño, Elvira Mora, José Falantes, Gemma Azaceta, Mariam Ibáñez, Tzu Chen, Cristina Notario, Neus Amer, Laura Palomo, Helena Pomares, Jordi Vila, Teresa Bernal del Castillo, Carlos Jiménez-Vicente, Daniel Esteban, Francesca Guijarro, José Álamo, Albert Cortés-Bullich, Víctor Torrecillas-Mayayo, Ana Triguero, Lucía Mont-de Torres, Ester Carcelero, Aina Cardús, Ulrich Germing, Beate Betz, Maria Rozman, Leonor Arenillas, Lurdes Zamora, María Díez-Campelo, Blanca Xicoy, Jordi Esteve, Marina Díaz-Beyá
Journal: Blood Advances
Blood Adv (2024) 9 (1): 39–53.
https://doi.org/10.1182/bloodadvances.2024013648
Published: 2024
Includes: Supplemental data
Journal Articles

Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML

Free
Clinical Trials & Observations
Lionel Adès, Larisa Girshova, Vadim A. Doronin, María Díez-Campelo, David Valcárcel, Suman Kambhampati, Nora-Athina Viniou, Dariusz Woszczyk, Raquel De Paz Arias, Argiris Symeonidis, Achilles Anagnostopoulos, Eduardo Ciliao Munhoz, Uwe Platzbecker, Valeria Santini, Robert J. Fram, Ying Yuan, Sharon Friedlander, Douglas V. Faller, Mikkael A. Sekeres
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5132–5145.
https://doi.org/10.1182/bloodadvances.2022007334
Published: 2022
Includes: Supplemental data